IH Interests: Route 92

Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
,
Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System
Route 92 Medical Announces $50 Million Series F Extension Equity Financing